Regional Disparities in the Use and Delivery of Adjuvant Radiation Therapy after Lumpectomy for Breast Cancer in the Medicare Population

Purpose: We examined radiation therapy (RT) use among patients with early-stage breast cancer and analyzed the contribution of patient, cancer, and regional factors to the likelihood of RT receipt across Health Service Areas. Methods and Materials: We identified 13,176 patients aged 66 to 79 years i...

Full description

Bibliographic Details
Main Authors: Gabriella Lui, Michael J. Hassett, MD, MPH, Angela C. Tramontano, MPH, Hajime Uno, PhD, Rinaa S. Punglia, MD, MPH
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109422001233
_version_ 1811261448519680000
author Gabriella Lui
Michael J. Hassett, MD, MPH
Angela C. Tramontano, MPH
Hajime Uno, PhD
Rinaa S. Punglia, MD, MPH
author_facet Gabriella Lui
Michael J. Hassett, MD, MPH
Angela C. Tramontano, MPH
Hajime Uno, PhD
Rinaa S. Punglia, MD, MPH
author_sort Gabriella Lui
collection DOAJ
description Purpose: We examined radiation therapy (RT) use among patients with early-stage breast cancer and analyzed the contribution of patient, cancer, and regional factors to the likelihood of RT receipt across Health Service Areas. Methods and Materials: We identified 13,176 patients aged 66 to 79 years in the Surveillance, Epidemiology, and End Results (SEER) Program–Medicare database who were diagnosed with lymph node–negative breast cancer in 2007 to 2011 and were treated with breast-conserving surgery. Patients were stratified as being at high risk or low risk for recurrence based on National Comprehensive Cancer Network Guidelines. Receipt of RT was studied with 5 modeling approaches to determine whether RT use and regional variation in its use changed based on the risk level of the cohort. Multivariable mixed-effects logistic regression was performed for each outcome. Choropleth maps were used to describe patterns of RT use. Results: Among high-risk patients, 70.1% received RT, compared with 72.6% of low-risk patients (P = .002). Among patients receiving RT, 60.9% were classified as high-risk, compared with 63.0% of patients who did not receive RT (P = .002). In multivariable analyses, patients in all rural areas had lower odds of receiving RT compared with the entire cohort (odds ratio [OR], 0.73; P < .001) and had lower odds of being high-risk and receiving RT (OR, 0.69; P < .001). Black patients (OR, 0.73; P = .001) and Asian patients (OR, 0.74; P = .004) had decreased likelihood of receiving RT compared with the entire cohort. The regional interclass correlation coefficient (ICC) for the model predicting receipt of RT among all patients was 0.05 and among low-risk patients was 0.06. The regional ICC dropped to 0.02 for the model predicting being both high-risk and receiving RT among all patients. Conclusions: We observed regional and racial and ethnic disparities in RT receipt among our cohort. Reassuringly, less regional variability was observed for RT receipt among those at high risk for recurrence. Future work is needed to understand the causes of these regional disparities to better serve patients who may benefit from treatment.
first_indexed 2024-04-12T19:04:34Z
format Article
id doaj.art-a3d72ca7312948a8a62eae513046bf7f
institution Directory Open Access Journal
issn 2452-1094
language English
last_indexed 2024-04-12T19:04:34Z
publishDate 2022-11-01
publisher Elsevier
record_format Article
series Advances in Radiation Oncology
spelling doaj.art-a3d72ca7312948a8a62eae513046bf7f2022-12-22T03:20:04ZengElsevierAdvances in Radiation Oncology2452-10942022-11-0176101017Regional Disparities in the Use and Delivery of Adjuvant Radiation Therapy after Lumpectomy for Breast Cancer in the Medicare PopulationGabriella Lui0Michael J. Hassett, MD, MPH1Angela C. Tramontano, MPH2Hajime Uno, PhD3Rinaa S. Punglia, MD, MPH4Departments of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Departments of Data Sciences, Dana-Farber Cancer Institute, Boston, MassachusettsDepartments of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, MassachusettsDepartments of Medical Oncology, Dana-Farber Cancer Institute, Boston, MassachusettsDepartments of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, MassachusettsDepartment of Radiation Oncology, Brigham &amp; Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Corresponding author: Rinaa S. Punglia, MD, MPHPurpose: We examined radiation therapy (RT) use among patients with early-stage breast cancer and analyzed the contribution of patient, cancer, and regional factors to the likelihood of RT receipt across Health Service Areas. Methods and Materials: We identified 13,176 patients aged 66 to 79 years in the Surveillance, Epidemiology, and End Results (SEER) Program–Medicare database who were diagnosed with lymph node–negative breast cancer in 2007 to 2011 and were treated with breast-conserving surgery. Patients were stratified as being at high risk or low risk for recurrence based on National Comprehensive Cancer Network Guidelines. Receipt of RT was studied with 5 modeling approaches to determine whether RT use and regional variation in its use changed based on the risk level of the cohort. Multivariable mixed-effects logistic regression was performed for each outcome. Choropleth maps were used to describe patterns of RT use. Results: Among high-risk patients, 70.1% received RT, compared with 72.6% of low-risk patients (P = .002). Among patients receiving RT, 60.9% were classified as high-risk, compared with 63.0% of patients who did not receive RT (P = .002). In multivariable analyses, patients in all rural areas had lower odds of receiving RT compared with the entire cohort (odds ratio [OR], 0.73; P < .001) and had lower odds of being high-risk and receiving RT (OR, 0.69; P < .001). Black patients (OR, 0.73; P = .001) and Asian patients (OR, 0.74; P = .004) had decreased likelihood of receiving RT compared with the entire cohort. The regional interclass correlation coefficient (ICC) for the model predicting receipt of RT among all patients was 0.05 and among low-risk patients was 0.06. The regional ICC dropped to 0.02 for the model predicting being both high-risk and receiving RT among all patients. Conclusions: We observed regional and racial and ethnic disparities in RT receipt among our cohort. Reassuringly, less regional variability was observed for RT receipt among those at high risk for recurrence. Future work is needed to understand the causes of these regional disparities to better serve patients who may benefit from treatment.http://www.sciencedirect.com/science/article/pii/S2452109422001233
spellingShingle Gabriella Lui
Michael J. Hassett, MD, MPH
Angela C. Tramontano, MPH
Hajime Uno, PhD
Rinaa S. Punglia, MD, MPH
Regional Disparities in the Use and Delivery of Adjuvant Radiation Therapy after Lumpectomy for Breast Cancer in the Medicare Population
Advances in Radiation Oncology
title Regional Disparities in the Use and Delivery of Adjuvant Radiation Therapy after Lumpectomy for Breast Cancer in the Medicare Population
title_full Regional Disparities in the Use and Delivery of Adjuvant Radiation Therapy after Lumpectomy for Breast Cancer in the Medicare Population
title_fullStr Regional Disparities in the Use and Delivery of Adjuvant Radiation Therapy after Lumpectomy for Breast Cancer in the Medicare Population
title_full_unstemmed Regional Disparities in the Use and Delivery of Adjuvant Radiation Therapy after Lumpectomy for Breast Cancer in the Medicare Population
title_short Regional Disparities in the Use and Delivery of Adjuvant Radiation Therapy after Lumpectomy for Breast Cancer in the Medicare Population
title_sort regional disparities in the use and delivery of adjuvant radiation therapy after lumpectomy for breast cancer in the medicare population
url http://www.sciencedirect.com/science/article/pii/S2452109422001233
work_keys_str_mv AT gabriellalui regionaldisparitiesintheuseanddeliveryofadjuvantradiationtherapyafterlumpectomyforbreastcancerinthemedicarepopulation
AT michaeljhassettmdmph regionaldisparitiesintheuseanddeliveryofadjuvantradiationtherapyafterlumpectomyforbreastcancerinthemedicarepopulation
AT angelactramontanomph regionaldisparitiesintheuseanddeliveryofadjuvantradiationtherapyafterlumpectomyforbreastcancerinthemedicarepopulation
AT hajimeunophd regionaldisparitiesintheuseanddeliveryofadjuvantradiationtherapyafterlumpectomyforbreastcancerinthemedicarepopulation
AT rinaaspungliamdmph regionaldisparitiesintheuseanddeliveryofadjuvantradiationtherapyafterlumpectomyforbreastcancerinthemedicarepopulation